Does TASIGNA Cause Malignant neoplasm progression? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Malignant neoplasm progression have been filed in association with TASIGNA. This represents 3.6% of all adverse event reports for TASIGNA.
28
Reports of Malignant neoplasm progression with TASIGNA
3.6%
of all TASIGNA reports
17
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TASIGNA?
Of the 28 reports, 17 (60.7%) resulted in death, 5 (17.9%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TASIGNA. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does TASIGNA Cause?
Death (76)
Fatigue (67)
Rash (53)
Nausea (42)
Dyspnoea (37)
Headache (31)
Chronic myeloid leukaemia (30)
Anaemia (27)
Electrocardiogram qt prolonged (27)
Pruritus (27)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TASIGNA Alternatives Have Lower Malignant neoplasm progression Risk?
TASIGNA vs TASIMELTEON
TASIGNA vs TAVABOROLE
TASIGNA vs TAXOL
TASIGNA vs TAXOTERE
TASIGNA vs TAZAROTENE